March 12, 2018 / 11:08 AM / 5 months ago

BRIEF-Aclaris Therapeutics Q4 Revenue $1.0 Mln

March 12 (Reuters) - Aclaris Therapeutics Inc:

* ACLARIS THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND PROVIDES UPDATE ON CLINICAL AND COMMERCIAL DEVELOPMENTS

* Q4 REVENUE VIEW $520,000 — THOMSON REUTERS I/B/E/S

* AS OF DECEMBER 31, 2017, HAD AGGREGATE CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES OF $208.9 MILLION

* ACLARIS THERAPEUTICS - EXPECTS CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES AS OF DEC 31, 2017 WILL BE SUFFICIENT TO FUND OPERATIONS INTO H2 2019 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below